Leading Infectious Disease Biomaterial Manufacturer

  • Copan FLOQSwab® and Liquid Control Products
    • Clinical Diagnostics,
    • Proficiency Programs,
    • Training, Verification and Development
  • Antigens for Diagnostic Test Manufacturers
  • Viral Transport Medium – DxTM™

Microbix Corporate Presentation — May 2022

Microbix Biosystems Inc. - Our Company Today. Download The Presentation Here >>

Microbix Reports Record Results for Q2 Fiscal 2022

Record Q2 Sales of $4.9 million, Q2 Net Earnings of $0.7 million MISSISSAUGA, May 12, 2022 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF,...

Microbix Presenting Omicron Test Control Results at CVS

QAPs Supporting Molecular Diagnostic Tests for Dominant COVID-variant MISSISSAUGA, CANADA, April 29, 2022 – Microbix Biosystems Inc. (TSX: MBX,...


Why choose Microbix Quality Assessment Products (QAPs)? Find out more.


Microbix produces one of the world’s broadest range of infectious disease antigens.


Microbix has a partnership opportunity. Check it out here.

Our Commitment to Quality

Our quality process ensures our customers receive products that meet and exceed their needs and expectations. Our quality management system takes into consideration regulatory requirements that are applicable to the type of products we manufacture and the industries we serve.